Clinical Diagnosis of Acute Appendicitis with Normal WBCS Count with Role of Inflammatory Markers and Radiology
1 other identifier
observational
50
1 country
1
Brief Summary
The aim of this study is to describe the proportion of pa-tients with normal preoperative inflammatorymarkers among patients with histopathologically proven acute appendicitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 31, 2025
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
February 19, 2025
February 1, 2025
2.7 years
January 31, 2025
February 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgery done if needed
Patient with acute appendicitis and normal WBCS count will be under observation for while but people with evidence on imaging and high inflammatory markers will go under surgery
Days of hospital reservation
Study Arms (1)
Patient included who have acute appendicitis clinically and normal WBCS count
Interventions
Open surgery for appendix which is inflamed
Eligibility Criteria
Study not need special type of people
You may qualify if:
- Male or female patients é clinically diagnosed acute appendicitis with normal WBCS
You may not qualify if:
- complicated AA (perforation, peri appendicular abscess or suspicion of a tumor.
- \_inflammatory bowel diseases 3\_inability to co-operate and give informed consent 4\_diffuse peritonitis 5\_Patients with serious comorbid conditions DM \& renal insufficiency, serum creatinine \> 150 μmol/l 6\_Pregnant \& lactating patient 7\_Patients with advanced malignancies \& pt on immunosuppressive drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assuit university
Asyut, Egypt
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Surgeon
Study Record Dates
First Submitted
January 31, 2025
First Posted
February 19, 2025
Study Start
January 1, 2025
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2028
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share